✦ LIBER ✦

IL-12/23p40-dependent clearance of Anaplasma phagocytophilum in the murine model of human anaplasmosis

✍ Scribed by Joao H.F. Pedra; Jian Tao; Fayyaz S. Sutterwala; Bindu Sukumaran; Nancy Berliner; Linda K. Bockenstedt; Richard A. Flavell; Zhinan Yin; Erol Fikrig

Book ID: 109308267
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 215 KB
Volume: 50
Category: Article
ISSN: 0928-8244
DOI: 10.1111/j.1574-695x.2007.00270.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development in the cynomolgus macaque fo

Development in the cynomolgus macaque following administration of ustekinumab, a human anti-il-12/23p40 monoclonal antibody, during pregnancy and lactation

✍ Pauline L. Martin; Clifford Sachs; Noritaka Imai; Hideshi Tsusaki; Satoru Oneda; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 544 KB

## Abstract **BACKGROUND:** Ustekinumab is a human monoclonal antibody that binds to the p40 subunit of interleukin (IL) 12 and IL‐23 and inhibits their pharmacological activity. To evaluate potential effects of ustekinumab treatment during pregnancy, developmental studies were conducted in cynomol

P017 The miRNA-29 family regulates NOD2-

P017 The miRNA-29 family regulates NOD2-dependent IL-23 expression in human DCs and limits intestinal pathology in a mouse model of mucosal inflammation

✍ Brain, O.; Owens, B.; Sun, M.-Y.; Schonefeldt, S.; Allan, P.; Pichulik, T.; Khat 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 53 KB

A Multicenter, Randomized, Double-Blind,

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase2b Study of Ustekinumab, a Human Monoclonal Antibody to IL-12/23p40, in Patients With Moderately to Severely Active Crohn's Disease: Results Through Week 22 From the Certifi Trial

✍ William J. Sandborn; Christopher Gasink; Long-Long Gao; Marion Blank; Jewel Joha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 145 KB